Search research articles
Contact Us
Filters
Showing results (11-20 of 45) with videos related to
Page
of 5
Sort By:
Journal of the American College of Cardiology
|
September 10, 2025
Let Us Call It Cardiogenic Preshock: A Working Definition From the Heart Failure Collaboratory
Vanessa Blumer, JoAnn Lindenfeld, Anuradha Lala, et al.
American Heart Journal
|
October 18, 2008
A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics
William T Abraham, Daniel Burkhoff, Koonlawee Nademanee, et al.
Journal of Cardiac Failure
|
February 10, 2010
Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial
Robert S McKelvie, Michel Komajda, John McMurray, et al.
American Heart Journal
|
August 2, 2017
Use of endpoint adjudication to improve the quality and validity of endpoint assessment for medical device development and post marketing evaluation: Rationale and best practices. A report from the cardiac safety research consortium
Jonathan H Seltzer, Ted Heise, Peter Carson, et al.
Congestive Heart Failure (Greenwich, Conn.)
|
July 25, 2009
Statin use is associated with improved survival in patients with advanced heart failure receiving resynchronization therapy
Andrew D Sumner, John P Boehmer, Leslie A Saxon, et al.
European Journal of Heart Failure
|
November 24, 2004
Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT
Henry Krum, Peter Carson, Csaba Farsang, et al.
The New England Journal of Medicine
|
November 10, 2004
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure
Anne L Taylor, Susan Ziesche, Clyde Yancy, et al.
Journal of Cardiac Failure
|
December 1, 2009
Relationship of quality of life scores with baseline characteristics and outcomes in the African-American heart failure trial
Peter Carson, S William Tam, Jalal K Ghali, et al.
JACC. Heart Failure
|
March 14, 2014
Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2)
Milton Packer, Peter Carson, Uri Elkayam, et al.
The American Journal of Cardiology
|
February 22, 2005
Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy
Christopher M O'Connor, Steven Gottlieb, Jamieson M Bourque, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 45) with videos related to
Sort By:
Page
of 5
Journal of the American College of Cardiology
|
September 10, 2025
Let Us Call It Cardiogenic Preshock: A Working Definition From the Heart Failure Collaboratory
Vanessa Blumer, JoAnn Lindenfeld, Anuradha Lala, et al.
American Heart Journal
|
October 18, 2008
A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics
William T Abraham, Daniel Burkhoff, Koonlawee Nademanee, et al.
Journal of Cardiac Failure
|
February 10, 2010
Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial
Robert S McKelvie, Michel Komajda, John McMurray, et al.
American Heart Journal
|
August 2, 2017
Use of endpoint adjudication to improve the quality and validity of endpoint assessment for medical device development and post marketing evaluation: Rationale and best practices. A report from the cardiac safety research consortium
Jonathan H Seltzer, Ted Heise, Peter Carson, et al.
Congestive Heart Failure (Greenwich, Conn.)
|
July 25, 2009
Statin use is associated with improved survival in patients with advanced heart failure receiving resynchronization therapy
Andrew D Sumner, John P Boehmer, Leslie A Saxon, et al.
European Journal of Heart Failure
|
November 24, 2004
Effect of valsartan added to background ACE inhibitor therapy in patients with heart failure: results from Val-HeFT
Henry Krum, Peter Carson, Csaba Farsang, et al.
The New England Journal of Medicine
|
November 10, 2004
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure
Anne L Taylor, Susan Ziesche, Clyde Yancy, et al.
Journal of Cardiac Failure
|
December 1, 2009
Relationship of quality of life scores with baseline characteristics and outcomes in the African-American heart failure trial
Peter Carson, S William Tam, Jalal K Ghali, et al.
JACC. Heart Failure
|
March 14, 2014
Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2)
Milton Packer, Peter Carson, Uri Elkayam, et al.
The American Journal of Cardiology
|
February 22, 2005
Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy
Christopher M O'Connor, Steven Gottlieb, Jamieson M Bourque, et al.
Page
of 5